PT Harum Energy Tbk (IDX:HRUM)

Revance Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	1,344	1,295	925.52	904.44	336.18	157.82
Revenue Growth (YoY)	30.50%	39.97%	2.33%	169.04%	113.01%	-39.90%
Cost of Revenue	1,094	1,012	543.12	362.94	162.68	114.58
Gross Profit	250.47	283.41	382.4	541.5	173.49	43.24
Selling, General & Admin	89.65	68	95.54	101.31	41.23	36.94
Operating Expenses	89.65	68	95.54	101.31	41.23	36.94
Operating Income	160.81	215.41	286.86	440.19	132.26	6.29
Interest Expense	-17.92	-12.78	-1.2	-1.28	-1.99	-0.23
Interest & Investment Income	7.76	7.76	19.36	2.52	2.62	3.95
Earnings From Equity Investments	-8.77	-6.94	24.91	39.09	5.83	-
Currency Exchange Gain (Loss)	-2.73	-2.73	-	-3.74	-0.19	8.78
Other Non Operating Income (Expenses)	15.79	-17.78	-4.24	-2.15	-1.97	-0.98
EBT Excluding Unusual Items	154.94	182.94	325.69	474.63	136.57	17.82
Gain (Loss) on Sale of Investments	-67.87	-67.87	-66.34	-	-10.64	46.51
Gain (Loss) on Sale of Assets	0.03	0.03	-0	2.91	0.04	0.1
Other Unusual Items	-	-	3.65	-	1.61	-
Pretax Income	87.1	115.11	263	477.55	127.57	64.42
Income Tax Expense	24.64	37.45	67.33	97.78	29.09	3.99
Earnings From Continuing Operations	62.46	77.66	195.67	379.77	98.48	60.43
Earnings From Discontinued Operations	-	-	-	-	-0.17	-0.14
Net Income to Company	62.46	77.66	195.67	379.77	98.31	60.29
Minority Interest in Earnings	-16	-23.59	-44.63	-78.02	-24.15	-1.29
Net Income	46.46	54.07	151.04	301.75	74.16	59
Net Income to Common	46.46	54.07	151.04	301.75	74.16	59
Net Income Growth	22.92%	-64.20%	-49.94%	306.88%	25.69%	218.87%
Shares Outstanding (Basic)	13,276	13,311	13,316	13,258	12,748	12,673
Shares Outstanding (Diluted)	13,276	13,311	13,316	13,258	12,748	12,673
Shares Change (YoY)	-0.23%	-0.04%	0.44%	4.00%	0.59%	-1.24%
EPS (Basic)	0.00	0.00	0.01	0.02	0.01	0.00
EPS (Diluted)	0.00	0.00	0.01	0.02	0.01	0.00
EPS Growth	23.20%	-64.20%	-50.17%	291.25%	24.96%	223.04%
Free Cash Flow	-512.4	-111.16	181.2	367.25	113.6	40.38
Free Cash Flow Per Share	-0.04	-0.01	0.01	0.03	0.01	0.00
Dividend Per Share	-	-	-	-	-	0.001
Gross Margin	18.63%	21.88%	41.32%	59.87%	51.61%	27.40%
Operating Margin	11.96%	16.63%	30.99%	48.67%	39.34%	3.99%
Profit Margin	3.46%	4.17%	16.32%	33.36%	22.06%	37.39%
Free Cash Flow Margin	-38.12%	-8.58%	19.58%	40.61%	33.79%	25.59%
EBITDA	221.25	281.42	341.51	471.42	149.06	20.99
EBITDA Margin	16.46%	21.72%	36.90%	52.12%	44.34%	13.30%
D&A For EBITDA	60.44	66.01	54.65	31.23	16.8	14.7
EBIT	160.81	215.41	286.86	440.19	132.26	6.29
EBIT Margin	11.96%	16.63%	30.99%	48.67%	39.34%	3.99%
Effective Tax Rate	28.29%	32.53%	25.60%	20.47%	22.80%	6.20%
Revenue as Reported	1,344	1,295	925.52	904.44	336.18	157.82

Updated Oct 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.